S

Surgical Science Sweden AB
STO:SUS

Watchlist Manager
Surgical Science Sweden AB
STO:SUS
Watchlist
Price: 129.3 SEK 0.62%
Market Cap: 6.6B SEK
Have any thoughts about
Surgical Science Sweden AB?
Write Note

Surgical Science Sweden AB
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Surgical Science Sweden AB
Operating Income Peer Comparison

Comparables:
EKTA B
CEVI
GETI B
ARJO B
S
STIL

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
S
Surgical Science Sweden AB
STO:SUS
Operating Income
kr147.8m
CAGR 3-Years
82%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Operating Income
kr2.4B
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Operating Income
kr183.8m
CAGR 3-Years
14%
CAGR 5-Years
7%
CAGR 10-Years
15%
Getinge AB
STO:GETI B
Operating Income
kr4.1B
CAGR 3-Years
-6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Operating Income
kr968m
CAGR 3-Years
1%
CAGR 5-Years
10%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Operating Income
kr61.9m
CAGR 3-Years
45%
CAGR 5-Years
20%
CAGR 10-Years
40%

See Also

What is Surgical Science Sweden AB's Operating Income?
Operating Income
147.8m SEK

Based on the financial report for Jun 30, 2024, Surgical Science Sweden AB's Operating Income amounts to 147.8m SEK.

What is Surgical Science Sweden AB's Operating Income growth rate?
Operating Income CAGR 3Y
82%

Over the last year, the Operating Income growth was -28%. The average annual Operating Income growth rates for Surgical Science Sweden AB have been 82% over the past three years .

Back to Top